LMR Partners LLP Sells 15,497 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

LMR Partners LLP reduced its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 59.3% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 10,615 shares of the medical equipment provider's stock after selling 15,497 shares during the period. LMR Partners LLP's holdings in Intuitive Surgical were worth $5,215,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently bought and sold shares of the business. Mirador Capital Partners LP lifted its stake in Intuitive Surgical by 1.4% in the third quarter. Mirador Capital Partners LP now owns 3,526 shares of the medical equipment provider's stock valued at $1,732,000 after acquiring an additional 50 shares during the last quarter. Advisors Asset Management Inc. raised its holdings in Intuitive Surgical by 18.1% during the first quarter. Advisors Asset Management Inc. now owns 7,380 shares of the medical equipment provider's stock valued at $2,945,000 after buying an additional 1,129 shares in the last quarter. Consolidated Planning Corp lifted its position in shares of Intuitive Surgical by 17.4% in the third quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider's stock worth $3,979,000 after buying an additional 1,198 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund boosted its stake in shares of Intuitive Surgical by 617.1% during the 2nd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 89,069 shares of the medical equipment provider's stock worth $39,622,000 after acquiring an additional 76,649 shares in the last quarter. Finally, ABLE Financial Group LLC bought a new stake in shares of Intuitive Surgical during the 3rd quarter worth about $604,000. Hedge funds and other institutional investors own 83.64% of the company's stock.

Intuitive Surgical Price Performance

Shares of ISRG traded up $7.18 during trading hours on Tuesday, hitting $538.82. The stock had a trading volume of 1,118,896 shares, compared to its average volume of 1,458,894. Intuitive Surgical, Inc. has a 52 week low of $304.50 and a 52 week high of $544.38. The stock has a market capitalization of $191.92 billion, a price-to-earnings ratio of 86.31, a P/E/G ratio of 5.19 and a beta of 1.39. The company's fifty day moving average is $500.33 and its two-hundred day moving average is $459.58.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, topping the consensus estimate of $1.24 by $0.32. The company had revenue of $2.04 billion during the quarter, compared to analyst estimates of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. Equities analysts predict that Intuitive Surgical, Inc. will post 5.45 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, insider Jamie Samath sold 269 shares of the firm's stock in a transaction that occurred on Monday, November 11th. The shares were sold at an average price of $539.89, for a total value of $145,230.41. Following the completion of the sale, the insider now owns 8,757 shares of the company's stock, valued at $4,727,816.73. This trade represents a 2.98 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, SVP Henry L. Charlton sold 40,243 shares of the company's stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $486.84, for a total value of $19,591,902.12. Following the transaction, the senior vice president now directly owns 3,001 shares in the company, valued at approximately $1,461,006.84. This represents a 93.06 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 91,178 shares of company stock valued at $45,897,071. 0.80% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on the company. Truist Financial increased their price target on Intuitive Surgical from $520.00 to $570.00 and gave the company a "buy" rating in a report on Monday, October 14th. Stifel Nicolaus boosted their target price on shares of Intuitive Surgical from $475.00 to $525.00 and gave the stock a "buy" rating in a research report on Friday, October 18th. Raymond James lifted their price objective on Intuitive Surgical from $500.00 to $540.00 and gave the stock an "outperform" rating in a research note on Monday, October 14th. BTIG Research set a $535.00 target price on Intuitive Surgical in a research note on Friday, October 18th. Finally, Oppenheimer reaffirmed a "market perform" rating on shares of Intuitive Surgical in a research report on Friday, October 18th. One research analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have issued a buy rating to the company's stock. Based on data from MarketBeat, Intuitive Surgical currently has an average rating of "Moderate Buy" and a consensus price target of $524.61.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.